Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: SYZONC, INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-09-29 to 2026-09-28
Current total value of award: $354878
Description: SBIR FY25 CONCEPT AWARD, TARGETING PLOD2 IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA